DEA Adds Benzimidazole-Opioids to Schedule I Drug List
The Drug Enforcement Administration is permanently placing the synthetic benzimidazole-opioids etodesnitazene, n-pyrrolidino etonitazene and protonitazene in Schedule I of the Controlled Substances Act, it said in a final order released April 10. The substances had already been temporarily listed in…
Sign up for a free preview to unlock the rest of this article
If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.
Schedule I since 2022 (see 2204110029). The final order is set to take effect April 11.